Related by context. All words. (Click for frequent words.) 79 BRCA1 mutations 77 BRCA2 mutation 76 BRCA mutations 75 BRCA mutation 74 BRCA2 carriers 73 BRCA2 gene mutation 73 BRCA2 mutation carriers 70 BRCA2 gene mutations 69 TGFBR1 * 6A 68 advanced adenoma 68 BRCA gene mutations 68 atypical hyperplasia 67 endometrial cancers 67 BRCA1 mutation carriers 67 BRCA2 genetic mutations 67 colorectal neoplasia 67 BRCA1 67 familial pancreatic cancer 67 BRCA gene mutation 67 mutated BRCA1 67 lobular cancer 66 adenomatous polyps 66 advanced adenomas 66 anal cancers 66 BRCA1 mutation 65 BRCA genes 65 noncarriers 65 BRCA2 gene 65 estrogen receptor negative 65 HNPCC 65 contralateral breast cancer 65 genes BRCA1 65 breast cancer genes BRCA1 65 ApoE4 gene 64 testicular germ cell 64 BRCA mutation carriers 64 chlamydial infection 64 prostate cancer CaP 64 KRAS mutations 64 prostate pancreatic 64 subclinical hyperthyroidism 64 APOE e4 64 anovulatory infertility 63 oophorectomy 63 lobular carcinoma 63 ovarian cancers 63 hereditary breast cancer 63 HNSCC 63 BRCA1 gene 63 hormone receptor negative 63 diffuse gastric 63 coinfected 63 APOE gene 63 BRCA carriers 63 nonmelanoma skin cancers 63 BRCA 63 MYH9 gene 63 narcolepsy cataplexy 63 uterine cancers 63 gallstone disease 63 ductal breast cancer 63 atypia 63 postmenopausal breast cancer 63 renal cell carcinomas 62 nonmelanoma skin cancer 62 colorectal adenomas 62 gene BRCA2 62 BRCA2 62 lobular breast cancer 62 tanned indoors 62 MetS 62 K ras mutations 62 atypical ductal hyperplasia 62 BRCA2 breast cancer 62 breast cancer susceptibility genes 62 faulty BRCA genes 62 premenopausal breast cancer 62 NAFLD 62 inherited mutations 62 operable breast cancer 62 oropharyngeal cancer 62 endometriosis ovarian cysts 62 breast endometrial 62 CC genotype 62 ε4 62 spontaneous preterm delivery 62 gynecologic malignancy 62 elevated CRP 62 polyp recurrence 62 BARD1 62 spontaneous preterm birth 62 rs# [001] 62 faulty BRCA2 gene 62 HGPIN 62 invasive ductal 61 basal cell nevus syndrome 61 adenoma 61 HER2 positive cancers 61 axillary lymph nodes 61 prophylactic mastectomy 61 colorectal cancers 61 recurrent VTE 61 hydroxyvitamin D levels 61 ovarian breast 61 APOE ε4 61 premenopausal 61 Li Fraumeni 61 transferrin saturation 61 colorectal polyps 61 elevated triglyceride levels 61 pCR 61 adenocarcinomas 61 advanced neoplasia 61 ABCB1 61 HPV genotypes 61 estrogen receptor positive 61 penetrance 61 APOL1 61 poor metabolizers 61 bladder cancers 61 HER2 expression 61 leukaemias 61 invasive breast cancer 61 abnormal Pap test 61 germline mutations 61 TT genotype 60 hormone receptor positive 60 CVD mortality 60 serous ovarian cancer 60 frequently benign tumor 60 slow metabolizers 60 BRCA2 genes 60 salpingo oophorectomy 60 colorectal polyp 60 elevated LDL cholesterol 60 TCF#L# gene 60 breast cancer gene mutation 60 APOE allele 60 ductal cancer 60 bowel polyps 60 ApoE4 60 Ashkenazi Jewish 60 colorectal cancer CRC 60 tibolone 60 CIN3 60 Uterine cancer 60 CHD mortality 60 epithelial ovarian cancer 60 thrombophilia 60 hormone therapy estrogen 60 abnormal mammograms 60 benign breast 60 perimenopausal women 60 IgA deficiency 60 BRAC2 60 thyrotropin levels 60 APOE4 60 bilateral oophorectomy 60 MSH2 60 endometrial carcinoma 60 MTHFR 60 ASCUS 60 rs# [002] 60 baseline HbA1c 60 proband 60 parous women 60 EGFR mutations 60 androgen deficiency 60 poorer prognosis 60 shorter telomere length 60 aged ≥ 60 CDKN2A 60 subclinical hypothyroidism 60 allele frequencies 60 elevated depressive symptoms 60 prostate adenocarcinoma 60 elevated triglycerides 60 locoregional recurrence 60 breast carcinoma 60 preterm deliveries 60 prescribed statins 60 uterine ovarian 60 endometrial cancer 59 female endoscopist 59 NNRTI resistance 59 PCa 59 invasive cervical cancer 59 carotid plaque 59 CDH1 59 GSTM1 59 TP# mutations 59 lobular involution 59 MLH1 59 mutated K ras 59 Apolipoprotein E4 59 ApoE4 allele 59 HER2 positive tumors 59 cerebral microbleeds 59 TCF#L# 59 BRCA1 BRCA2 59 distal colon cancer 59 apolipoprotein E gene 59 nondiabetic 59 grade cervical intraepithelial 59 KIF6 gene 59 gestational hypertension 59 Hurthle cell 59 UGT#A# * 59 lung adenocarcinoma 59 serum selenium 59 cognitively normal 59 venous thrombosis 59 dysglycemia 59 TMEM#B 59 esophageal adenocarcinoma 59 deCODE BreastCancer TM 59 chromosomal abnormalities 59 flutamide 59 gestational diabetes mellitus 59 preventive mastectomies 59 FGFR2 59 familial hypercholesterolemia 59 MYCN amplification 59 precursor lesions 59 inherited predisposition 59 ovarian tumors 59 chromosomal disorders 59 vertebral fracture 59 Colon polyps 59 colon cancers 59 HER2 overexpression 59 telomere lengths 59 postoperative delirium 59 folate intake 59 pre eclamptic 59 familial ALS 59 seronegative 59 CIN2 + 59 acrylamide intake 59 undergone radical prostatectomy 59 carotid stenosis 59 testosterone supplementation 59 intestinal polyps 59 Folic acid supplements 59 colorectal tumors 59 #q# deletion 59 apolipoprotein E4 59 intravenous bisphosphonates 59 polycystic ovary syndrome PCOS 59 gene APOE 59 invasive ductal breast cancer 59 estrogen receptor ER 58 micrometastases 58 recurrent UTI 58 histologic subtype 58 ORMDL3 58 hereditary predisposition 58 undergone hysterectomies 58 highest quintile 58 colorectal cancer incidence 58 missense mutations 58 progesterone receptor negative 58 CHD CVD 58 liver transplant recipients 58 radical nephrectomy 58 pancreatic adenocarcinoma 58 taxane therapy 58 T1DM 58 dizygotic twins 58 cervical carcinoma 58 non pledgers 58 C#Y 58 seropositivity 58 colorectal adenoma 58 estrogen progestin therapy 58 subclinical atherosclerosis 58 dopamine receptor gene 58 LRP5 58 testicular cancers 58 thyroid hormone levels 58 HBeAg negative 58 Ovary removal 58 LQTS 58 undergone hysterectomy 58 MGUS 58 nonpregnant women 58 gene mutations 58 malignant polyps 58 VUR 58 GISTs 58 #q# [001] 58 born preterm 58 CCR5 delta# 58 SHBG levels 58 osteosarcomas 58 p# mutation 58 CHEK2 58 vulvar cancers 58 varicocele 58 MELD scores 58 G allele 58 confidence interval #.#-#.# 58 APOE e4 gene 58 peritoneal cancer 58 invasive carcinoma 58 bowel cancers 58 postmenopausal hormone 58 precancerous cervical 58 oesophageal adenocarcinoma 58 GnRH agonists 58 axillary node dissection 58 Adjuvant chemotherapy 58 relapsed ALL 58 serum PSA 58 coinfection 58 ovarian endometrial 58 latent tuberculosis infection 58 untreated celiac disease 58 apolipoprotein E 58 thromboembolisms 58 drank decaffeinated coffee 58 tumor histology 58 abnormal Pap smears 58 thalassemia trait 58 invasive lobular 58 familial clustering 58 preterm delivery 58 rs# [004] 58 endometrial hyperplasia 58 genetic variants associated 58 HbF 58 benign proliferative breast 58 TOMM# 58 APOE genotype 58 colorectal cancer 58 ovarian pancreatic 58 HPV# 58 neuroblastomas 58 HIV uninfected 58 HBsAg 58 recurrent miscarriages 58 chronic HBV infection 58 lipid abnormalities 58 T2DM 58 lung ovary 57 CYP#C# [001] 57 extracolonic findings 57 anal HPV 57 Fragile X gene 57 prophylactic mastectomies 57 squamous cell lung cancer 57 colorectal neoplasms 57 chorioamnionitis 57 singleton pregnancy 57 microdeletions 57 ADPKD 57 Premenopausal women 57 anal lesions 57 prostate cancers 57 situ LCIS 57 p# mutations 57 atrophic gastritis 57 pre menopausal 57 recurrent miscarriage 57 CIN2 57 abnormal glucose tolerance 57 abnormal cytology 57 fetal chromosomal 57 lymph node metastases 57 cardiovascular mortality 57 coronary artery calcium 57 obstructive coronary artery 57 thyroid cancers 57 EGFR mutation 57 cTnT 57 fasting glucose levels 57 screening colonoscopy 57 cancerous prostates removed 57 elevated ALT 57 cervical breast 57 probands 57 nonalcoholic steatohepatitis NASH 57 skeletal metastases 57 nonvertebral fractures 57 SLNB 57 de ath 57 meningiomas 57 ErbB2 positive 57 postmenopausal hormones 57 disease NAFLD 57 seminoma 57 IKZF1 57 breast ovarian 57 autoantibody positive 57 Pancreatic neuroendocrine tumors 57 basal cell carcinoma BCC 57 cervical intraepithelial neoplasia 57 urine cytology 57 PSA velocity 57 KIF6 carriers 57 pancreatic prostate 57 5 HTTLPR 57 AAT deficiency 57 axillary dissection 57 habitual snoring 57 pharyngeal cancer 57 HPV subtypes 57 aneuploidy 57 olaparib 57 hematopoietic cancers 57 adenomas 57 neural tube defect 57 chlamydia infection 57 V Leiden 57 #.#ng/ml 57 BRAF mutation 57 PCA3 scores 57 colon tumors 57 GBA mutations 57 pancreatic cancers 57 Genetic variants 57 fasting triglyceride levels 57 rectal cancers 57 GSTT1 57 symptomatic fibroids 57 GIST tumors 57 CaP 57 sporadic ALS 57 invasive ductal carcinoma 57 monozygotic twins 57 mesotheliomas 57 genetic abnormalities 57 distant metastases 57 BRCA testing 57 beta carotene supplementation 57 vaginal cancers 57 lignan intake 57 axillary nodes 57 microscopic colitis 57 HER2 negative 57 PTPN# 57 progestins 57 facial clefts 57 osteoporotic fractures 56 genital HPV infections 56 liver metastasis 56 BRIP1 56 LPA gene 56 TP# mutation 56 lymph node involvement 56 Digital Mammographic Imaging 56 Uterine fibroids 56 antigen PSA 56 chronic HBV 56 Menopausal hormone therapy 56 medulloblastomas 56 lipid lowering medications 56 mammographic density 56 gastric carcinoma 56 variant allele 56 Epidemiologic studies 56 Adenomas 56 SORL1 56 genital tract infections 56 Radical prostatectomy 56 nonfasting triglyceride levels 56 BRAF V#E 56 TACI mutations 56 undescended testes 56 hormone receptor status 56 adnexal mass 56 venous thromboembolic events 56 neoplasias 56 tumor subtypes 56 dietary fiber intake 56 ovaries removed 56 genes CYP#C# 56 HBV infection 56 breast cancers 56 invasive ductal carcinomas 56 neoplasia 56 external genital lesions 56 nodal metastasis 56 histological subtype 56 familial predisposition 56 BRCA gene 56 CARDIA 56 congenital toxoplasmosis 56 irregular menstrual cycles 56 gastric cardia 56 genotyped 56 Human papilloma virus 56 serum uric acid 56 sCJD 56 microscopic hematuria 56 clinically insignificant 56 chronic periodontitis 56 shorter telomeres 56 Asymptomatic 56 breast uterine 56 Thyroid nodules 56 venous thromboembolism 56 varicoceles 56 prostate specific 56 hepatocellular carcinomas 56 colorectal lung 56 contralateral breast 56 PALB2 56 medically inoperable 56 histologically confirmed 56 CMV infection 56 gastric cancers 56 HPV infections 56 Malignant tumors 56 SPINK1 56 uveal melanoma 56 initiating HAART 56 BCG vaccinated 56 nulliparous women 56 carotid plaques 56 dietary calcium intake 56 KRAS wild 56 TRAF1 C5 56 leiomyomas 56 latent TB infection 56 metastatic prostate 56 recurrent ovarian cancer 56 albumin excretion 56 grade serous ovarian 56 serum vitamin D 56 singleton pregnancies 56 rectal gonorrhea 56 HIV HCV coinfected 56 genital HPV infection 56 prostate carcinoma 56 gastrointestinal cancers 56 homocysteine concentrations 56 colorectum 56 breast cancer gene mutations 56 familial adenomatous polyposis 56 AML MDS 56 polycystic ovary syndrome 56 plasma folate 56 acute leukemias 56 familial aggregation 56 breast cancer subtypes 56 cranial irradiation 56 HLA DQ2 56 deleterious mutation 56 testicular tumors 56 squamous cell cancers 56 hsCRP levels 56 Hepatitis B virus 56 androgen deprivation 56 EpCAM expression 56 densest breasts 56 Klinefelter syndrome 56 abnormal Pap 56 placental malaria 56 ALCL 56 Complication rates 56 LTBI 56 microbleeds 56 abnormal pap smears 56 malignant pleural mesothelioma 56 ovarian carcinoma 56 abnormal mammogram 56 NP CRNs 56 lobular carcinomas 56 Cholangiocarcinoma 56 elevated hsCRP 56 FLT3 mutations 56 severe renal impairment 56 coronary calcification 56 ALND 56 postoperative mortality 56 Myelodysplastic syndromes MDS 56 HCV antibody 56 mosaicism 56 adiponectin concentrations 56 severe periodontitis 56 chromosomal rearrangement 56 GSTP1 56 axillary node 56 decompensated liver disease 56 serum lipid levels 56 genital ulcers 56 CYP#D# gene 56 gene variants 56 Li Fraumeni syndrome 56 preventive mastectomy 56 unexplained stillbirth 56 Ashkenazi Jews 56 folate supplementation 56 distant metastasis 56 unmeasured factors 56 Prostate Lung Colorectal 56 colon polyps 56 seroconverted 56 urinary BPA 56 genetic variant 56 highest tertile 56 KRAS mutation 56 C. trachomatis 56 lung colorectal 56 calcium intakes 56 NHANES III 56 atherogenic dyslipidemia 56 nonsmall cell lung cancer 56 hamartomas 56 extracolonic 56 adjuvant radiation 56 nonhereditary 56 TYMS 56 monozygotic twin 56 MMSE scores 56 tamoxifen therapy 56 MYH9 56 node metastases 56 cervical lesions 56 endometrial ovarian 56 prostate ovarian 56 B7 H3 56 malignant neoplasm 56 PARP inhibition 56 clinicopathologic 56 repeat allele 56 MLL2 56 genital HPV 55 penile cancers 55 HER2 amplified 55 chromosomal anomalies 55 KRAS oncogene 55 LSIL 55 hyperandrogenism 55 Genetic variations 55 acute lymphoid leukemia 55 fetal malformations 55 2 diabetes T2D 55 undergo prostate biopsy 55 pancreatic lung 55 BRCA1 gene mutation 55 kaempferol 55 metabolically healthy 55 gene variation 55 fetuin 55 invasive lobular carcinoma 55 basal cell carcinomas 55 rs# [003] 55 denser breasts 55 microsatellite instability 55 oral clefts 55 sulphonylureas 55 colon rectal 55 esophageal cancers 55 nondepressed 55 Framingham Offspring Study 55 Subgroup analyzes 55 PGDH 55 ovarian cancer 55 underwent prostatectomy 55 gestational diabetes mellitus GDM 55 malignant lesions 55 asymptomatic carotid stenosis 55 Helicobacter pylori infection 55 statin medications 55 CYP#A# gene 55 BRAF mutations 55 Trichomonas vaginalis 55 adjuvant chemotherapy 55 BMPR2 55 urethritis 55 BRAF V#E mutation 55 CMV disease 55 undergoing radical prostatectomy 55 homozygotes 55 TOP2A 55 CYP#D# 55 thyroid nodules 55 resistant hormone refractory 55 pre cancerous polyps 55 esophageal squamous cell carcinoma 55 premature menopause 55 overexpress HER2 55 breast pancreatic 55 PSA screening 55 hypermethylated 55 HIV seropositive 55 fraternal twin pairs 55 cerebral infarction 55 VKORC1 55 haemorrhagic stroke 55 del 5q MDS 55 pelvic lymphadenectomy 55 recurrent NSCLC 55 Squamous 55 PTEN mutations 55 coronary artery calcification 55 carotid IMT 55 renal tumors 55 breast conserving 55 monozygotic 55 primary ovarian insufficiency 55 lung cancer NSCLC 55 Prostatitis 55 elevated serum creatinine 55 nonmetastatic 55 white matter hyperintensities 55 AUDs 55 genetic polymorphisms 55 FGFR2 gene 55 flavonoid intake 55 squamous cell carcinomas 55 breast cancer recurrences 55 abnormal lipid levels 55 sentinel nodes 55 nondrinkers 55 nonselective NSAIDs 55 2D 4D ratio 55 chromosomal aberrations 55 abnormal Pap smear 55 onset diabetes mellitus 55 elevated LDL 55 microvascular disease 55 Testicular cancer 55 hypovitaminosis D 55 thyrotropin 55 RET PTC rearrangements 55 pheochromocytomas 55 modifiable risk 55 cervical vulvar 55 thiopurine 55 Basal cell 55 folic acid takers 55 metachronous 55 relapsed MM 55 EBV infection 55 hyperplasia BPH 55 nondemented 55 ovarian lung 55 HER2 amplification 55 molecular subtypes 55 T1c 55 abnormal lipid 55 HCV infection 55 adenoma recurrence 55 promoter methylation 55 Hashimoto thyroiditis 55 colorectal bowel 55 TEAEs 55 colorectal carcinomas 55 dizygotic 55 postmenopausal 55 Polycystic ovary syndrome PCOS 55 LCIS 55 squamous cell skin 55 genes predisposing 55 mIU L 55 screening colonoscopies 55 mIU ml 55 tumor recurrence 55 estrogen metabolites 55 atherothrombosis 55 Malignant gliomas 55 HPV infection 55 catheter angiography 55 obese postmenopausal 55 MAOA L 55 MC1R 55 APOC3 55 cryptorchidism 55 System IPSS 55 neurodevelopmental impairment 55 gonococcal infections 55 subependymal giant cell 55 cutaneous melanoma 55 heterozygous 55 CP CPPS 55 atypical moles 55 fibroids endometriosis 55 deletion 5q 55 situ DCIS 55 endometrial kidney 55 prostate carcinogenesis 55 Ishak fibrosis score 55 papillary renal cell carcinoma 55 precancer 55 homozygous 55 PSADT 55 variant alleles 55 vaginal lesions 55 MC1R gene 55 LHRH receptor positive 55 Schaffir 55 serum PTH 55 Homocysteine levels 55 serum calcium levels 55 lymph node biopsies 55 unfavorable genotypes 55 gene predisposing 55 undergo radical prostatectomy 55 chlamydial infections 55 serum estradiol 55 nonalcoholic steatohepatitis 55 gene variant 55 dose ionizing radiation 55 #q#.# deletion syndrome 55 Heavy menstrual bleeding 55 NMIBC 55 ductal carcinomas 55 nulliparous 55 Chlamydia infection 55 DQB1 * 55 Colorectal cancer incidence 55 EUS FNA 55 systemic lupus erythematosus SLE 55 osteoporotic fracture 55 Human papillomavirus 55 neoplasia PIN 55 Kufs disease 55 pelvic malignancies 55 CETP VV 55 K ras mutation 55 psychiatric comorbidities 55 genital herpes infections 55 premenopausal women 55 hereditary breast 55 undergoing bariatric surgery 55 fecal occult blood 55 #p# [001] 55 precancerous colon polyps 55 spontaneous mutations 55 GSTM1 gene 55 grade gliomas 55 Routine screening 54 asymptomatic PAD 54 nodal metastases 54 oral bisphosphonates 54 gastric cancer 54 Amniocentesis 54 CYP#C# [002] 54 proximal colon 54 angiotensin receptor blockers ARBs 54 elevated LDH 54 Fatty Liver Disease 54 PCNSL 54 Premenopausal 54 CYP#D# genotype 54 heterozygotes 54 chromosomal alterations 54 KRAS status 54 biochemical relapse 54 unexplained infertility 54 obese adolescents 54 somatic mutations 54 grade squamous intraepithelial 54 HPV types 54 HPV 54 lipid elevations 54 CYP#C# * 54 unresectable tumors 54 KRAS mutations occur 54 sentinel lymph node biopsy 54 papillary thyroid cancer 54 cosmetic breast implants 54 autoimmune thyroid 54 G6PD deficiency 54 Colorectal cancers 54 late onset hypogonadism 54 HBV infections 54 kidney allograft 54 Rectal cancer 54 #q#.# [001] 54 EGFR mutation status 54 Cytogenetic 54 abdominally obese 54 lymphocytosis 54 univariate analyzes 54 triplet pregnancies 54 anaplastic lymphoma kinase 54 serum calcium 54 biochemical recurrence 54 #mg/dL [001] 54 oropharyngeal cancers 54 colorectal carcinoma 54 carry BRCA mutation 54 TNF blocker therapy 54 promoter hypermethylation 54 mtDNA mutations 54 untreated chlamydia 54 troponin T 54 situ CIS 54 genital ulcer disease 54 Clusterin 54 definite stent thrombosis 54 hyperphenylalaninemia HPA due 54 cystatin C 54 BRCA deficient 54 coinfected patients 54 diagnosed prenatally 54 adenocarcinoma 54 intestinal metaplasia 54 ductal lobular 54 hydroxyvitamin D concentrations 54 adiponectin levels 54 oncogenic HPV 54 Wactawski Wende 54 fructose intolerance 54 ZNF# 54 breast carcinomas 54 serum folate concentrations 54 subfertility 54 alleles 54 lymphomas leukemias 54 paternal lineages 54 Stomach cancer 54 impair fertility 54 lymphoproliferative disorders 54 malignancy 54 pancreatic neuroendocrine tumors 54 nonischemic 54 radiosensitive 54 delaying childbirth 54 hypogonadal 54 malignancies 54 oligodendrogliomas 54 LHRH agonists 54 pg ml 54 APOE4 gene 54 seminomas 54 serum creatinine levels 54 ApoE 54 pleural mesothelioma 54 post menopausal 54 soft tissue sarcomas 54 CNVs 54 abdominal adiposity 54 MTHFR gene 54 Anal cancer 54 Gastric cancer 54 aromatase inhibitors AIs 54 ERBB2 54 symptomatic BPH 54 NOMID 54 UGT#B# 54 hypercholesterolemia 54 APOE 54 progesterone receptor PR 54 drank colas 54 nonmelanoma 54 preoperative chemotherapy 54 recessive genetic disorders 54 vaginal hysterectomy 54 histologies 54 gastric carcinogenesis 54 breast cancer recurrence 54 bronchopulmonary dysplasia BPD 54 impaired fasting glucose 54 cancers 54 breastfed exclusively 54 nonvertebral fracture 54 endogenous estrogen 54 elevated homocysteine 54 myeloproliferative neoplasms 54 Screening Trial 54 premenstrual syndrome PMS 54 serum phosphate 54 gene polymorphism 54 clefting 54 CTAP# Capsules 54 distal colon 54 Leukemias 54 congenital malformations 54 genetic syndromes 54 prostates removed 54 GPC5 54 mg BID dose 54 TMPRSS2 ERG 54 onset idiopathic hypogonadism 54 latent celiac disease 54 Recurrence Score 54 methylation markers 54 nonseminoma 54 cause cardiac channelopathies 54 hyperemesis gravidarum 54 hormonally responsive 54 dietary folate intake 54 neurologic complications 54 grade cervical dysplasia 54 % CI #.#-#.# [005] 54 cervix uteri 54 Folate deficiency 54 seropositive 54 thyroid dysfunction 54 invasive cervical cancers 54 epididymitis 54 ApoE gene 54 medullary thyroid cancer 54 lymphatic cancers